Resources

Novel Coronavirus (COVID-19) Vaccine Development – Wave 4

Given the ongoing roll-out of the COVID-19 vaccine across the US, InCrowd conducted its fourth wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and further predictions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors (n=101)
    • Other Specialists (n=300)
  • Screening Criteria:
    • Physicians identifying as at least somewhat familiar with vaccines in development for COVID-19
  • Fielding Period:
    • Mar 1st – 3rd, 2021

Please fill out the form below to access this content

Related Resources

Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more
Dobbs Decision After 18-Months 

Dobbs Decision After 18-Months 

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb's decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the...

read more